D5BI:XETRA:XETRA-Xtrackers MSCI Mexico UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 5.45

Change

+0.08 (+1.43)%

Market Cap

USD 0.27B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.12 (+2.20%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.35 (+2.11%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.53 (+1.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.62 (+2.20%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.54 (+2.19%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+3.00 (+2.11%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.83 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.06 (+2.08%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.72 (-0.13%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.43 (+1.86%)

USD 79.79B

ETFs Containing D5BI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.16% 5% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.16% 5% F 9% A-
Trailing 12 Months  
Capital Gain -6.31% 7% C- 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.31% 7% C- 14% F
Trailing 5 Years  
Capital Gain 40.77% 61% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.77% 59% D- 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 18.09% 92% A 89% A-
Dividend Return 18.09% 92% A 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.54% 21% F 33% F
Risk Adjusted Return 92.59% 93% A 93% A
Market Capitalization 0.27B 52% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.